WAT Medical Enterprise Ltd. of Vancouver at MEDICA 2018 in Düsseldorf -- MEDICA - World Forum for Medicine

WAT Medical Enterprise Ltd.

Unit 170, 422 Richards St., V6B 2Z4 Vancouver
Canada
Telephone +1 604 3850656
Fax +1 604 4483008

This company is co-exhibitor of
Canadian German Chamber of Industry and Commerce Inc.

Hall map

MEDICA 2018 hall map (Hall 16): stand F46

Fairground map

MEDICA 2018 fairground map: Hall 16

Contact

Anne Ge

Marketing &Sales Dept.

Raymond Ji

CEO

Our range of products

Product categories

  • 01  Electromedical Equipment / Medical Technology
  • 01.04  Therapy and physical medicine
  • 01.04.02  Electro-therapy equipment

Our products

Product category: Electro-therapy equipment

EmeTerm-Anti Nausea and Vomiting Wristband

Principle:
EmeTerm is an anti-nausea and vomiting wristband that uses electric impulses to stimulate targeted vomiting central in the brain, and precisely blocks the signal of nausea and vomiting from brain to stomach.

Application:
It can be effective for a wide range of treatments, including :
  • Motion Sickness
  • Morning Sickness 
  • Medicine(CINV&PONV)
Features:
--Patented Ergonomics Designs, no Conduct Gel Needed. Convenient and Low Allergy.
--Targeted Neuro Modulation. Drug-free and Quick Effect.
--Clinically Proven for Vomiting and Nausea.
--Winner of iF Design Award 2017.

EmeTerm has been recognized by various medical device administrations worldwide, including:
EU– CE Certification
US – FDA Certification
Canada – HC Certification
Australia – TGA Certification

More Less

Product category: Electro-therapy equipment

HeadaTerm- Anti Migraine Head Patch

Principle:
HeadaTerm is an anti-migraine patch that uses none-invasive external Trigeminal Nerve Stimulation (eTNS) technology that introduces precise electric impulses from the user's forehead to act on the supratrochlear nerves and reduce the migraine signals transmitted.

Application:
It can be effective for migraine and any kind of primary headache, including:
  • Cluster Headache 
  • Tension Headache
  • Insomnia
Features:
--Targeted Neuro Modulation. Drug Free and Without any Side Effect.
--Direct Therapy. Quick Effect.
--Affordable and Containing  21 Therapies.
--Small and Light. Easy to Carry.
--Clinically Proven for Primary Headache and Insomnia.

HeadaTerm has been recognized by various medical device administrations worldwide, including:
EU– CE Certification
Canada – HC Certification
Australia – TGA Certification

More Less

Company news

Date

Topic

Download

Jul 27, 2018

EmeTerm Anti-Nausea and Vomiting Wristband is FDA Cleared

WAT Medical's leading product to treat nausea-induced vomiting, EmeTerm, has received its FDA clearance earlier in April. Now ready to officially enter the U.S. market as an effective medical treatment. WAT Medical is thrilled to bringing its innovative technology to help the millions of people who suffer from such conditions. The product is effective for a wide range of treatments, including all types of motion sickness induced by travelling and morning sickness from pregnancy. It is safe and cleared by FDA to be used for pregnancy-induced nausea and vomiting. EmeTerm is medication-free and doesn't have drug side effects like dizziness, drowsiness and increasing in the thickness of lung secretions.

EmeTerm's technology is called neuro modulation which is FDA cleared and clinical proven. The electric current is send to nerve system via P6 acupuncture point on underside of the wrist. The targeted electric pulses are delivered to brain and precisely block the signal of nausea and vomiting from brain to stomach. EmeTerm are currently used by consumers in over 20 counties worldwide.

EmeTerm is the winner of 2017 iF Design Award for its innovative design and usability. The patented electrodes design enhanced the transfer of electric pulses from device to skin. No conduct gel is needed which could bring more convenient and affordability to consumers. 

WAT Medical's anti-migraine device, HeadaTerm, is also in the process of FDA clearance, and is estimated to enter the U.S. market along with EmeTerm in the following months.

More Less

Jul 28, 2017

HeadaTerm (TM): The Cost Would Not Add Pain to Migraine Patients

The team from migraine.com conducted a survey in 2016 titled: "Migraine in America" with the goal to gain a better understanding of the challenges faced by migraine patients. Over 3,900 people completed the 145-question survey.

The results show that:

Over 36% of the patients spent over $1,000 per year on migraine related treatments.
64% of the patients have avoided therapy because of the cost.
62% of the patients asked their doctors for cheaper prescriptions.
50% of the patients skipped entire dosages to make their prescriptions last longer.
The impact of migraine on one's life can be overwhelming and far-reaching, negatively affecting personal relationships, ability to work or to attend school.

HeadaTerm Principle

HeadaTerm uses none-invasive external Trigeminal Nerve Stimulation (eTNS) technology that introduces precise electric impulses from the user's forehead to act on the supratrochlear nerves and reduce the migraine signals transmitted. The device avoids any drug effects, making it appropriate a wide range of users. eTNS has been clinically used for migraine and other conditions for over 40 years and was proven to be safety and effective.

What HeadaTerm contributed is making the therapy affordable - the device is low cost and it reduces the consume of medications. HeadaTerm is particularly helpful for sufferers with frequent migraine. The usage of medications would be reduced and the patient's quality of life to be improved. 

The product design is usability-based. Very portable design makes the therapy available at any place any time. LED light and buzzer indicates the status of device and keeps communicating with user. Easy shutter. Attached mirror helps user to position device. Arc-shaped device match easily with forehead.

HeadaTerm has medical level standard. It's CE-certified medical device to prevent and treat primary headache. It is estimated to be approved by FDA and Health Canada by early 2018. The manufacturer, WAT Medical, is certified to the ISO medical standard.

Low Cost Solution

HeadaTerm costs $29.00 per device. One device contains 21 rounds of standard therapies; each therapy lasts 20 minutes. HeadaTerm is designed to be an affordable innovative technology that provides access to a drug-free treatment for primary headaches.

More Less

About us

Company details

WAT Medical is a company that develops safe, effective, and user-friendly wearable medical products.  With the devoted and leading it owns staff in the field of medical research and development, an efficient and convenient medical service is being provided for worldwide individual customers.  

We understand the side effects of current medications and hope to provide a comfortable treatment to patients. As a result, we developed a drug-free treatment that uses precise transcutaneous electrical nerve stimulation (TENS) that are specialized to target certain areas of the body for specific functions. Reduced drug dosage effectively.

The number of our intellectual property rights has reached more than 60 pcs around the world. All of our products are Certified by its international medical institutions in the world including CE0123, FDA510k, Health Canada, TGA etc.

We already distributed our Brand in more than 20 counties worldwide within one year and gained a lot of praises.

Our mission: supplying innovative self-care medical device.

More Less

Company data

Number of employees

20-49

Area of business

Electromedical equipment / Medical Technology